Nearly everyone knows that GLP-1s are very effective in treating diabetes and obesity, but they may not realize that these drugs are already approved to address several other conditions with limited ...

Despite some recent improvements, millions of Americans still face significant barriers in affording GLP-1s. At the same time, many patients have found alternative, cheaper paths to get their hands on ...

Hailed by some as miracle drugs, GLP-1s have surged in popularity in the past few years. An estimated one out of every eight Americans is now on some version of them and scientists continue to ...

OMAHA, Neb. (WOWT) - Flood water caused the most damage in Omaha’s Karen Addition following last night’s storm. People living in the neighborhood, located next to the Little Papio Creek, are ...

Noom, the popular weight-loss app, prompts its users not only to log their meals and exercise but also to gaze at paintings. The “Mindful Art Break” feature includes images of such works as Claude ...

A series of complaints filed within the last year focus on a specific condition called non-arteritic anterior ischemic optic neuropathy, or NAION, which causes rapid-onset vision changes and loss that ...

Diabetes drugs have shown surprising benefits for the heart, kidneys, and brain. Now provocative animal research suggests they may influence the biology of aging itself. New evidence that semaglutide ...

PepsiCo (PEP) is making a more strategic move beyond shelf-stable chips, soda, and packaged snacks into new areas of the grocery store, including refrigerated, produce-adjacent, deli, dip, and ...

For decades, obesity medications produced only modest weight loss. But in recent years, Ozempic and related GLP-1 therapies have transformed the field, enabling sustained weight loss of 10 to 15% or ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. GLP-1 medications, initially known for significant weight loss and diabetes management, are ...

There is little debate over which Wall Street profit story is the biggest of the moment: artificial intelligence. For second-biggest, consider the case for GLP-1 drugs. Tokenization of financial ...

Good Monday morning in New York City, where drivers in the Bronx have figured out how to get away with double-parking in bus lanes. Gothamist is funded by sponsors and member donations Gothamist is ...